INS and Hypoglycemia: After 6 months, similar improvements in HbA1c were reported in both those who were switched to an FRC or to basal insulin with a gliflozin compared to those managed with a basal-bolus regimen, with the added benefit of fewer daily injections, less hypoglycemia, and no weight gain.